Mediwatch PLC - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Mediwatch PLC. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Mediwatch PLC. The Group's principal activity is developing primary care products used in the diagnosis of urological disorders and early prostate cancer detection. Its operation focuses on such areas urology, bladder assessment, erectile dysfunction, urogynaecology, incontinence and near-patient testing. The Group operates in three divisions: ultrasound, urodynamics and biochemistry. Its products include Portascan+, Multiscan and Multiscan PVR in ultrasound; Urodyn 1000, Portaflow, Duet Logic G2, Duet Encompass and Duet Logic Sensic G3, Disposables and Erectease in urodynamics and PSAWatch, Bioscan and BTA in biochemistry. The Group operates predominantly in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report